GR1003969B - Σταθερα φαρμακευτικα διαλυματα νιμεσουλιδης. - Google Patents

Σταθερα φαρμακευτικα διαλυματα νιμεσουλιδης.

Info

Publication number
GR1003969B
GR1003969B GR20010100050A GR2001100050A GR1003969B GR 1003969 B GR1003969 B GR 1003969B GR 20010100050 A GR20010100050 A GR 20010100050A GR 2001100050 A GR2001100050 A GR 2001100050A GR 1003969 B GR1003969 B GR 1003969B
Authority
GR
Greece
Prior art keywords
solutions
nimesulide
stable pharmaceutical
glycerine
formaldehyde
Prior art date
Application number
GR20010100050A
Other languages
English (en)
Inventor
Original Assignee
U��-Pharma ����� ������ ������������ ���������� ����
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by U��-Pharma ����� ������ ������������ ���������� ���� filed Critical U��-Pharma ����� ������ ������������ ���������� ����
Priority to GR20010100050A priority Critical patent/GR1003969B/el
Priority to AT01600015T priority patent/ATE284685T1/de
Priority to PT01600015T priority patent/PT1228757E/pt
Priority to ES01600015T priority patent/ES2233589T3/es
Priority to EP01600015A priority patent/EP1228757B1/en
Priority to DK01600015T priority patent/DK1228757T3/da
Priority to DE60107804T priority patent/DE60107804T2/de
Priority to SI200130284T priority patent/SI1228757T1/xx
Publication of GR1003969B publication Critical patent/GR1003969B/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

παρούσα εφεύρεση έχει σχέση με σταθερά φαρμακευτικά διαλύματα Νιμεσουλίδης που αποτελούνται απο 80% Γλυκερινική Φορμαλδεύδη, 15% Αιθανόλη, νερό 5% ή και Γλυκερινική Φορμαλδεύδη, 10% Αιθανόλη, 10% Προπυένογλυκόλη και 5% νερό. Τα διαλύματα αυτά είναι κατάλληλα για την Παρασκευή Φαρμακευτικών μορφών παρεντερικής χορήγησης για θεραπευτικούς σκοπούς. ΰ
GR20010100050A 2001-02-05 2001-02-05 Σταθερα φαρμακευτικα διαλυματα νιμεσουλιδης. GR1003969B (el)

Priority Applications (8)

Application Number Priority Date Filing Date Title
GR20010100050A GR1003969B (el) 2001-02-05 2001-02-05 Σταθερα φαρμακευτικα διαλυματα νιμεσουλιδης.
AT01600015T ATE284685T1 (de) 2001-02-05 2001-06-05 Stabile pharmazeutische nimesulidverbindungen
PT01600015T PT1228757E (pt) 2001-02-05 2001-06-05 Solucoes farmaceuticas estaveis de nimesulida
ES01600015T ES2233589T3 (es) 2001-02-05 2001-06-05 Soluciones farmaceuticas estables de nimesulida.
EP01600015A EP1228757B1 (en) 2001-02-05 2001-06-05 Stable pharmaceutical solutions of nimesulide
DK01600015T DK1228757T3 (da) 2001-02-05 2001-06-05 Stabile farmaceutiske oplösninger af nimesulid
DE60107804T DE60107804T2 (de) 2001-02-05 2001-06-05 Stabile pharmazeutische Nimesulidverbindungen
SI200130284T SI1228757T1 (en) 2001-02-05 2001-06-05 Stable pharmaceutical solutions of nimesulide

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GR20010100050A GR1003969B (el) 2001-02-05 2001-02-05 Σταθερα φαρμακευτικα διαλυματα νιμεσουλιδης.

Publications (1)

Publication Number Publication Date
GR1003969B true GR1003969B (el) 2002-08-14

Family

ID=10944630

Family Applications (1)

Application Number Title Priority Date Filing Date
GR20010100050A GR1003969B (el) 2001-02-05 2001-02-05 Σταθερα φαρμακευτικα διαλυματα νιμεσουλιδης.

Country Status (8)

Country Link
EP (1) EP1228757B1 (el)
AT (1) ATE284685T1 (el)
DE (1) DE60107804T2 (el)
DK (1) DK1228757T3 (el)
ES (1) ES2233589T3 (el)
GR (1) GR1003969B (el)
PT (1) PT1228757E (el)
SI (1) SI1228757T1 (el)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0146414A2 (en) * 1983-12-22 1985-06-26 Merck & Co. Inc. Antiparasitic non-aqueous formulation containing an avermectin or milbemycin
EP0916347A1 (en) * 1997-11-18 1999-05-19 Uni-Pharma Kleon Tsetis A.B.E.E., Farmakeftika Ergastiria Pharmaceutical injectable solutions containing paracetamol and combinations of paracetamol with other active substances
EP1002531A1 (en) * 1998-01-12 2000-05-24 Panacea Biotec Limited A water-miscible composition of non-steroidal antiinflammatory drugs
WO2000048588A1 (en) * 1999-02-16 2000-08-24 Farmaceutici Formenti S.P.A. Pharmaceutical topical compositions containing a non-steroidal antiinflammatory drug

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0146414A2 (en) * 1983-12-22 1985-06-26 Merck & Co. Inc. Antiparasitic non-aqueous formulation containing an avermectin or milbemycin
EP0916347A1 (en) * 1997-11-18 1999-05-19 Uni-Pharma Kleon Tsetis A.B.E.E., Farmakeftika Ergastiria Pharmaceutical injectable solutions containing paracetamol and combinations of paracetamol with other active substances
EP1002531A1 (en) * 1998-01-12 2000-05-24 Panacea Biotec Limited A water-miscible composition of non-steroidal antiinflammatory drugs
WO2000048588A1 (en) * 1999-02-16 2000-08-24 Farmaceutici Formenti S.P.A. Pharmaceutical topical compositions containing a non-steroidal antiinflammatory drug

Also Published As

Publication number Publication date
PT1228757E (pt) 2005-04-29
DE60107804D1 (de) 2005-01-20
ATE284685T1 (de) 2005-01-15
EP1228757B1 (en) 2004-12-15
DK1228757T3 (da) 2005-03-14
SI1228757T1 (en) 2005-06-30
EP1228757A1 (en) 2002-08-07
ES2233589T3 (es) 2005-06-16
DE60107804T2 (de) 2005-12-22

Similar Documents

Publication Publication Date Title
IT1318649B1 (it) Composizioni farmaceutiche per il trattamento di mucositi e stomatiti.
BR9902086A (pt) Formulações farmacêuticas.
TR200200579T2 (tr) Amino-tirazolpiridin türevleri.
HN2001000244A (es) Inhibidores de espiropirimidin - 2, 4, 6 - triona metaloproteinasas.
EP1423107A4 (en) FATTY ALCOHOL DRUG CONJUGATES
DE60143363D1 (de) Pharmazeutische zusammensetzungen, die die immunogenität von schwach immunogenen antigenen fördern
ATE238981T1 (de) Antitumorwirkstoffe
MY133112A (en) 3-amino-3-arylpropan-1-ol derivatives, and their preparation and use
SE0003476D0 (sv) Compounds
EE200300129A (et) Distamütsiini alfa-halogenoakrüloüülderivaadi kasutamine
PT1107793E (pt) Conjugados de dextrano-leptina, composicoes farmaceuticas e processos relacionados
TR200402070T4 (tr) Siklobüten-dion türevleri ve bunların damar sertliği tedavisinde kullanımı
ATE266029T1 (de) Substituierte pyrrolobenzimidazolderivate zur entzündungshemmung
MXPA03011128A (es) Composicion de sabor y fragancia.
SE9802209D0 (sv) Novel compounds
ITMI20001695A0 (it) Procedimento per la preparazione di composizioni organico-sili-coniche.
GR1003969B (el) Σταθερα φαρμακευτικα διαλυματα νιμεσουλιδης.
ITMI20000293A0 (it) Derivati del 3,9-diazabiciclo [3.3.1]nonano ad attivita' analgesica
CY1111290T1 (el) Παραγωγα 9-αλκυλαμινo-1-νιτρoακριδινης
SE0001631D0 (sv) New use
IT1320082B1 (it) Procedimento per la realizzazione di reggiseni, nonche' reggisenocosi' ottenuto.
IT1317818B1 (it) Procedimento per la produzione di componenti per integratorialimentari, formulazioni dietetiche, cosmetiche e farmaceutiche,
SE9802207D0 (sv) Novel compounds
UA81617C2 (en) Chalcone derivatives and their use
ITMI20001600A1 (it) Procedimento per la preparazione di 5-amino-4-alo-3-alchil isossazoli.